FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

1495581000168106: List of Medicines for Brand Consideration reference set (foundation metadata concept)


Status: current, Primitive. Date: 30-Sep 2020. Module: Third party reference set module

Descriptions:

Id Description Lang Type Status Case? Module
4462321000168116 List of Medicines for Brand Consideration reference set (foundation metadata concept) en Fully specified name Active Initial character case insensitive Third party reference set module
4462331000168118 List of Medicines for Brand Consideration reference set en Synonym Active Initial character case insensitive Third party reference set module
4462411000168119 List of Medicines for Brand Consideration (LMBC) reference set en Synonym Active Initial character case insensitive Third party reference set module
4462641000168118 <p>Supports the identification of AMT Medicinal Product Unit of Use (MPUU) and Medicinal Product Pack (MPP) concepts associated with the List of Medicines for Brand Consideration (LMBC) that forms part of the Active Ingredient Prescribing initiative. Under the <i>National Health (Pharmaceutical Benefits) Regulations 2017</i>, the <i>Repatriation Pharmaceutical Benefits Scheme Instrument 2013</i> and <i>MRCA Pharmaceutical Benefits Scheme Instrument 2013</i>, all PBS and RPBS prescriptions must be prepared by active ingredient, the brand may additionally be identified if a prescriber considers it necessary. The LMBC supports prescribers' decision-making regarding the inclusion of brand on a prescription.</p><p>This reference set can be used by prescribing software vendors to identify medications for brand consideration to meet Active Ingredient Prescribing requirements.</p><p><b>Target Client:&nbsp;</b>This reference set was developed by the National Clinical Terminology Service for the Australian Government Department of Health and Aged Care to support the Active Ingredient Prescribing initiative, and can be used by developers to assist with the requirements.</p> en Definition Active Case sensitive Third party reference set module


1324 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
List of Medicines for Brand Consideration reference set Is a Reference sets for Medications true Inferred relationship Some
List of Medicines for Brand Consideration reference set Is a Simple type reference set true Inferred relationship Some
List of Medicines for Brand Consideration reference set Developed by Australian Government Department of Health and Aged Care true Inferred relationship Some 1570063879

Members
trastuzumab 60 mg injection, 1 vial
trastuzumab 60 mg injection, vial
trastuzumab emtansine 100 mg injection, 1 vial
trastuzumab emtansine 100 mg injection, vial
trastuzumab emtansine 160 mg injection, 1 vial
trastuzumab emtansine 160 mg injection, vial
warfarin sodium 1 mg tablet
warfarin sodium 1 mg tablet, 50
warfarin sodium 1 mg tablet, 500
warfarin sodium 2 mg tablet
warfarin sodium 2 mg tablet, 50
warfarin sodium 2 mg tablet, 500
warfarin sodium 3 mg tablet
warfarin sodium 3 mg tablet, 50
warfarin sodium 5 mg tablet
warfarin sodium 5 mg tablet, 50
warfarin sodium 5 mg tablet, 500
zuclopenthixol acetate 100 mg/2 mL injection, ampoule
zuclopenthixol acetate 100 mg/2 mL injection, 5 x 2 mL ampoules
zuclopenthixol acetate 50 mg/mL injection, ampoule
zuclopenthixol acetate 50 mg/mL injection, 1 mL ampoule
zuclopenthixol acetate 50 mg / 1 mL injection, 5 x 1 mL ampoules (medicinal product pack)
zuclopenthixol decanoate 200 mg/mL injection, ampoule
zuclopenthixol decanoate 200 mg/mL injection, 5 x 1 mL ampoules

Start Previous Page 14 of 14


Reference Sets

Australian dialect reference set

Reference set descriptor

Back to Start